Researchers Identify Potential 'Regenerative Switch' in Mammals

Researchers at the Texas A&M College of Veterinary Medicine and Biomedical Sciences have identified a potential method to trigger tissue regeneration in mammals, challenging the long-held belief that humans are biologically incapable of regrowing complex body parts. By utilizing a two-stage treatment involving specific growth factors, the team successfully redirected the body's natural healing response away from traditional scar tissue formation and toward the development of functional bone, joints, and ligaments.

Typically, mammalian healing relies on fibrosis, where fibroblast cells prioritize rapid wound closure through scarring to prevent infection. While effective for survival, this process creates a physical barrier that prevents the regrowth of complex structures. The study suggests that mammalian cells possess a latent capacity for regeneration similar to that of salamanders, but this ability is currently suppressed by the body's default preference for scar formation. The researchers discovered that by applying fibroblast growth factor 2 (FGF2) followed by bone morphogenetic protein 2 (BMP2) in a precise sequence, they could coax these cells to form a blastema—a foundational structure necessary for tissue regrowth.

This breakthrough has significant implications for regenerative medicine and trauma care. If this process can be refined for human application, it could fundamentally change how clinicians treat severe injuries and amputations, moving beyond simple wound management toward true biological restoration. While the current results are not yet perfect replicas of original anatomy, the ability to manipulate cellular behavior to favor growth over scarring represents a major shift in our understanding of mammalian biology and opens new avenues for future therapeutic interventions.